MLICM
SCPH

Metropolitan Life Insurance Company (MetLife)’s scPharmaceuticals SCPH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-343
Closed -$1.72K – 1742
2024
Q1 		$1.72K Sell
343
-26
-7% -$146 ﹤0.01% 2293
2023
Q4 		$2.31K Sell
369
-1,219
-77% -$6.98K ﹤0.01% 2314
2023
Q3 		$11.3K Hold
1,588
– – ﹤0.01% 2158
2023
Q2 		$16.2K Buy
+1,588
New +$16.6K ﹤0.01% 2044

Other funds holding SCPH

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SCPH Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of scPharmaceuticals (SCPH) in Q2 2024, closing a stake of 343 shares — an estimated $1.72K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SCPH in Q2 2023 and held it in 4 quarters. The position peaked at $16.2K in Q2 2023. 77 funds tracked by Wall St. Rank hold SCPH as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining scPharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 343 scPharmaceuticals shares in Q2 2024, an estimated $1.72K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in scPharmaceuticals in Q2 2023 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s scPharmaceuticals position peaked at $16.2K in Q2 2023.
  • 77 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.